MCM Group

News

Two Humboldt Fellows at HITS

01 07 2019

Since 2012, HITS has been the host for eight fellows of the Humboldt foundation. This year, the institute was glad to welcome …

Read more

Wade and Nunes Alves on boards of the JCIM

03 05 2019

Recently, HITS researchers from the Molecular and Cellular Modeling (MCM) group have been appointed to boards of the Journal of Chemical …

Read more

New & Special: The state-of-the-art of ‘Molecular Modeling in Drug Design’

17 01 2019

New Special Issue in the journal ‘Molecules’ out on the state-of-the-art of ‘Molecular Modeling in Drug Design’ guest edited by Rebecca …

Read more

The need for speed: Why malaria parasites are faster than human immune cells

20 07 2018

Elementary cytoskeleton protein is different in parasites and represents a starting point for a possible new therapy against malaria infections. Researchers …

Read more

New computational method for drug discovery

11 07 2018

HITS researchers developed tauRAMD, a tool to predict drug-target residence times from short simulations. The method is illustrated on the cover …

Read more

Accelerated reactions in condensed bio-matter?

19 06 2018

HITS researcher Dr. Kashif Sadiq explores ribonucleoprotein granules, a condensed form of bio-matter found inside cells. He investigates whether the rate …

Read more

EuroNeurotrophin project starts

01 03 2018

14 Early Stage Researchers to be trained in a European training network for the discovery of small molecule neurotrophin mimetics as candidate …

Read more

A matter of mobility: multidisciplinary paper suggests new strategy for drug discovery

15 01 2018

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The …

Read more

Click here to go to the German home page.